Literature DB >> 26910758

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Involved in Adult Mouse Hippocampal Neurogenesis After Stroke.

Minako Matsumoto1, Tomoya Nakamachi2, Jun Watanabe3, Koichi Sugiyama1, Hirokazu Ohtaki4, Norimitsu Murai4, Shun Sasaki1, Zhifang Xu4, Hitoshi Hashimoto5,6,7, Tamotsu Seki4, Akira Miyazaki1, Seiji Shioda8.   

Abstract

In the subgranular zone (SGZ) of the hippocampus, neurogenesis persists throughout life and is upregulated following ischemia. Accumulating evidence suggests that enhanced neurogenesis stimulated by ischemic injury contributes to recovery after stroke. However, the mechanisms underlying the upregulation of neurogenesis are unclear. We have demonstrated that a neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), exerts a wide range of effects on neural stem cells (NSCs) during neural development. Here, we examined the effects of endogenous and exogenous PACAP in adult NSCs of the SGZ. Immunostaining showed expression of the PACAP receptor PAC1R in nestin-positive NSCs of adult naive mice. PACAP injection into the lateral ventricle increased bromodeoxyuridine (BrdU)-positive proliferative cells in the SGZ. These data suggest that PACAP promoted the proliferation of NSCs. In global ischemia model mice, the number of BrdU-positive cells was increased in wild-type mice but not in PACAP heterozygous knockout mice. The BrdU-positive cells that increased in number after ischemia were immunopositive for SOX2, a marker of NSCs, and differentiated into NeuN-positive mature neurons at 4 weeks after ischemia. These findings suggest that PACAP contributes to the proliferation of NSCs and may be associated with recovery after brain injury.

Entities:  

Keywords:  Global ischemia; Hippocampus; Neurogenesis; Pituitary adenylate cyclase-activating polypeptide

Mesh:

Substances:

Year:  2016        PMID: 26910758     DOI: 10.1007/s12031-016-0731-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  43 in total

1.  IL-6 and PACAP receptor expression and localization after global brain ischemia in mice.

Authors:  Tomoya Nakamachi; Masashi Tsuchida; Nobuyuki Kagami; Sachiko Yofu; Yoshihiro Wada; Motohide Hori; Daisuke Tsuchikawa; Akira Yoshikawa; Nori Imai; Keisuke Nakamura; Satoru Arata; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2012-06-06       Impact factor: 3.444

2.  Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat.

Authors:  D Reglodi; A Somogyvari-Vigh; S Vigh; T Kozicz; A Arimura
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

3.  Role of endogenous pituitary adenylate cyclase-activating polypeptide in adult hippocampal neurogenesis.

Authors:  Y Ago; M Yoneyama; T Ishihama; S Kataoka; K Kawada; T Tanaka; K Ogita; N Shintani; H Hashimoto; A Baba; K Takuma; T Matsuda
Journal:  Neuroscience       Date:  2010-10-23       Impact factor: 3.590

4.  Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways.

Authors:  Kenji Dohi; Hidekatsu Mizushima; Shigeo Nakajo; Hirokazu Ohtaki; Seiji Matsunaga; Tohru Aruga; Seiji Shioda
Journal:  Regul Pept       Date:  2002-11-15

Review 5.  Adult neural stem cells: response to stroke injury and potential for therapeutic applications.

Authors:  Basam Z Barkho; Xinyu Zhao
Journal:  Curr Stem Cell Res Ther       Date:  2011-12       Impact factor: 3.828

Review 6.  Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo.

Authors:  D Reglodi; P Kiss; A Lubics; A Tamas
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 7.  Role of PACAP in neural stem/progenitor cell and astrocyte--from neural development to neural repair.

Authors:  Tomoya Nakamachi; Jozsef Farkas; Jun Watanabe; Hirokazu Ohtaki; Kenji Dohi; Satoru Arata; Seiji Shioda
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 8.  Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.

Authors:  A Arimura
Journal:  Jpn J Physiol       Date:  1998-10

9.  Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils.

Authors:  J Liu; K Solway; R O Messing; F R Sharp
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

10.  Expression and distribution of pituitary adenylate cyclase-activating polypeptide receptor in reactive astrocytes induced by global brain ischemia in mice.

Authors:  Tomoya Nakamachi; Jozsef Farkas; Nobuyuki Kagami; Yoshihiro Wada; Motohide Hori; Daisuke Tsuchikawa; Masashi Tsuchida; Akira Yoshikawa; Nori Imai; Tomohiko Hosono; Satoru Atrata; Seiji Shioda
Journal:  Acta Neurochir Suppl       Date:  2013
View more
  18 in total

1.  Early Neurobehavioral Development of Mice Lacking Endogenous PACAP.

Authors:  Jozsef Farkas; Balazs Sandor; Andrea Tamas; Peter Kiss; Hitoshi Hashimoto; Andras D Nagy; Balazs D Fulop; Tamas Juhasz; Sridharan Manavalan; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2017-02-06       Impact factor: 3.444

2.  The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.

Authors:  A Vaczy; D Reglodi; T Somoskeoy; K Kovacs; E Lokos; E Szabo; A Tamas; T Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

3.  Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.

Authors:  Sebastian Bardosi; Attila Bardosi; Zsuzsanna Nagy; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

4.  PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.

Authors:  Timea Kvarik; Barbara Mammel; Dora Reglodi; Krisztina Kovacs; Dora Werling; Brigitta Bede; Alexandra Vaczy; Eszter Fabian; Gabor Toth; Peter Kiss; Andrea Tamas; Tibor Ertl; Judit Gyarmati; Tamas Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

5.  Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood-Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats.

Authors:  Yuanjian Fang; Hui Shi; Reng Ren; Lei Huang; Takeshi Okada; Cameron Lenahan; Marcin Gamdzyk; Zachary D Travis; Qin Lu; Lihui Tang; Yi Huang; Keren Zhou; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Neurotherapeutics       Date:  2020-09-11       Impact factor: 7.620

Review 6.  PACAP deficiency as a model of aging.

Authors:  D Reglodi; T Atlasz; E Szabo; A Jungling; A Tamas; T Juhasz; B D Fulop; A Bardosi
Journal:  Geroscience       Date:  2018-10-22       Impact factor: 7.713

7.  Effect of controlled cortical impact on the passage of pituitary adenylate cyclase activating polypeptide (PACAP) across the blood-brain barrier.

Authors:  Elizabeth M Rhea; Kristin M Bullock; William A Banks
Journal:  Peptides       Date:  2017-10-28       Impact factor: 3.750

Review 8.  Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art.

Authors:  Marialuisa Gandolfi; Nicola Smania; Antonio Vella; Alessandro Picelli; Salvatore Chirumbolo
Journal:  Neural Plast       Date:  2017-03-08       Impact factor: 3.599

Review 9.  Protective effects of PACAP in ischemia.

Authors:  Dora Reglodi; Alexandra Vaczy; Eloísa Rubio-Beltran; Antoinette MaassenVanDenBrink
Journal:  J Headache Pain       Date:  2018-03-02       Impact factor: 7.277

10.  Pituitary adenylate cyclase-activating polypeptide (PACAP) modulates dependence-induced alcohol drinking and anxiety-like behavior in male rats.

Authors:  Valentina Sabino; Pietro Cottone; Antonio Ferragud; Clara Velazquez-Sanchez; Margaret A Minnig
Journal:  Neuropsychopharmacology       Date:  2020-11-16       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.